Exhibit 10.7
NRC INTERNAL USE: HHT -- PP&A | # A-0042398 (Orig. A-0039781) | Page 1 of 2 |
 |
Amendment 3 to Technology License Agreement |
| BUSINESS CONFIDENTIAL – PROTECTED B |
AMENDED ANNEX A – Stable Cells
Stable Cells to be provided to Licensee through the Service Provider
| 1) | CHO2353TM stable pool expressing the stabilized trimeric Wuhan spike protein antigen |
| 2) | CHO2353TM stable pool expressing the stabilized trimeric South African spike protein antigen |
| 3) | CHO2353TM stable pool expressing the stabilized trimeric DELTA Variant spike protein antigen |
| 4) | CHO2353TM stable pool expressing the stabilized trimeric OMICRON Variant spike protein antigen |
For clarity, Additional Stable Cells could be added to the list upon obtaining the NRC’s prior written approval, satisfying all the NRC’s requirements in this respect and the payment of relevant fees as per stated in section 2.6.2 of the Original Agreement.
NRC INTERNAL USE: HHT -- PP&A | # A-0042398 (Orig. A-0039781) | Page 2 of 2 |